$246.45
0.40%
NYSE, Sep 18, 04:20 pm EDT. Closed.
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Target price 2026 - Analyst rating & recommendation

Quest Diagnostics Classifications & Recommendation

Buy
57%
Hold
43%

Quest Diagnostics Price Target

Target Price $255.00
Price $246.45
Potential
Number of Estimates 18
18 Analysts have issued a price target Quest Diagnostics 2027 . The average Quest Diagnostics target price is $255.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 13 Analysts recommend Quest Diagnostics to buy, 10 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2027 of . Most analysts recommend the Quest Diagnostics stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 11.04 12.12
11.78% 9.81%
EBITDA Margin 16.36% 19.89%
5.20% 21.60%
Net Margin 8.95% 10.26%
2.06% 14.59%

20 Analysts have issued a sales forecast Quest Diagnostics 2026 . The average Quest Diagnostics sales estimate is

$12.1b
unlock
. This is
4.83% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$12.7b 10.22%
unlock
, the lowest is
$11.6b 0.42%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $11.0b 11.78%
2026
$12.1b 9.81%
unlock
2027
$12.7b 4.62%
unlock
2028
$13.2b 4.24%
unlock
2029
$13.5b 2.36%
unlock
2030
$13.4b 0.62%
unlock

17 Analysts have issued an Quest Diagnostics EBITDA forecast 2026. The average Quest Diagnostics EBITDA estimate is

$2.4b
unlock
. This is
31.41% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.7b 44.77%
unlock
, the lowest is
$2.2b 21.59%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $1.8b 17.59%
2026
$2.4b 33.52%
unlock
2027
$2.6b 8.67%
unlock
2028
$2.7b 4.96%
unlock

EBITDA Margin

2025 16.36% 5.20%
2026
19.89% 21.60%
unlock
2027
20.66% 3.87%
unlock
2028
20.80% 0.68%
unlock

21 Quest Diagnostics Analysts have issued a net profit forecast 2026. The average Quest Diagnostics net profit estimate is

$1.2b
unlock
. This is
17.51% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.3b 25.43%
unlock
, the lowest is
$1.2b 13.30%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $988m 14.09%
2026
$1.2b 25.84%
unlock
2027
$1.3b 7.52%
unlock
2028
$1.5b 8.77%
unlock
2029
$1.6b 7.86%
unlock
2030
$1.6b 4.99%
unlock
2031
$1.8b 7.49%
unlock

Net Margin

2025 8.95% 2.06%
2026
10.26% 14.59%
unlock
2027
10.54% 2.73%
unlock
2028
11.00% 4.36%
unlock
2029
11.59% 5.36%
unlock
2030
12.25% 5.69%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 8.74 11.30
14.10% 29.29%
P/E 21.81
EV/Sales 2.66

21 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is

$11.30
unlock
. This is
19.70% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$12.06 27.75%
unlock
, the lowest is
$10.90 15.47%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $8.74 14.10%
2026
$11.30 29.29%
unlock
2027
$12.15 7.52%
unlock
2028
$13.22 8.81%
unlock
2029
$14.26 7.87%
unlock
2030
$14.97 4.98%
unlock
2031
$16.09 7.48%
unlock

P/E ratio

Current 26.11 19.47%
2026
21.81 16.46%
unlock
2027
20.28 7.02%
unlock
2028
18.65 8.04%
unlock
2029
17.29 7.29%
unlock
2030
16.46 4.80%
unlock
2031
15.32 6.93%
unlock

Based on analysts' sales estimates for 2026, the Quest Diagnostics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.79 13.88%
2026
2.66 4.71%
unlock
2027
2.54 4.42%
unlock
2028
2.44 4.07%
unlock
2029
2.38 2.31%
unlock
2030
2.40 0.63%
unlock

P/S ratio

Current 2.35 21.05%
2026
2.24 4.61%
unlock
2027
2.15 4.41%
unlock
2028
2.06 4.07%
unlock
2029
2.01 2.30%
unlock
2030
2.02 0.62%
unlock

Current Quest Diagnostics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
Locked
Locked Sep 08 2026
JP Morgan
Locked
Locked
Locked Jul 28 2026
Mizuho
Locked
Locked
Locked Jul 24 2026
Truist Securities
Locked
Locked
Locked Jul 24 2026
UBS
Locked
Locked
Locked Jul 24 2026
Barclays
Locked
Locked
Locked Jul 24 2026
Baird
Locked
Locked
Locked Jul 24 2026
Analyst Rating Date
Locked
UBS:
Locked
Locked
Sep 08 2026
Locked
JP Morgan:
Locked
Locked
Jul 28 2026
Locked
Mizuho:
Locked
Locked
Jul 24 2026
Locked
Truist Securities:
Locked
Locked
Jul 24 2026
Locked
UBS:
Locked
Locked
Jul 24 2026
Locked
Barclays:
Locked
Locked
Jul 24 2026
Locked
Baird:
Locked
Locked
Jul 24 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today